Editorial Board

Dr. Jiang completed a surgical pathology and gastrointestinal pathology fellowships at Emory University School of Medicine. Dr. Jiang’s clinical interest is in gastrointestinal pathology, including both neoplastic diseases and medical/ infectious processes and pancreatobiliary and liver pathology, including neoplasms and medical liver diseases. His research interests are to identify tumor markers during cancer initiation and progression in gastrointestinal, hepatic and pancreatobiliary neoplasms, so as to aid in the diagnoses and prognostication of these diseases.

Gastrointestinal, Pancreatobiliary Pathology, Cancer,

Dr. Dongkyoo Park is a Postdoctoral Fellow in the Department of Radiation Oncology at Winship Cancer Institute Emory University, Atlanta, GA, USA. He completed his Ph.D. degree program in Medical Sciences-Molecular Cell Biology at University of Florida, Gainesville, FL, USA. He is an associate member of the American Association for Cancer Research (AACR), an editorial board member of Cancer Prime, and a guest editor of Contrast Media & Molecular Imaging. He is mainly investigating the anti-cancer drug development. He has published more than 17 peer reviewed research and review articles in top journals in the field of cancer research. His research posters were also presented in several conferences and he was awarded with Best Poster in Cancer Biology at 6th Annual Postdoctoral Fellow Research Symposium, Atlanta, GA, USA.

Anti-cancer drug development; Apoptosis; Lung cancer; Head & Neck cancer; Liver cancer; Tumor radioresistance; Tumor chemoresistance; Mouse cancer models; Immunotherapy; Space radiation; Theranostics.

The biology of cancer is the main field of research that fascinated Dr. Saad Sabbar Dahham. He is interested in targeting tumors by inhibiting angiogenesis and understanding other mechanisms that are at play which can influence angiogenesis. In the last few years, he started his research on natural product and their roles against cancer cells. With the wide experience in the biological sciences, he published many articles in Scopus and ISI journals and presented abstracts in many worldwide conferences. A part of angiogenesis interest, he recently won the gold award in the International Conference and Exposition on Inventions by Institutions of Higher Learning (PECIPTA 2015) for invented Mu-DermTM (A natural angiogenic product for wound healing).

Microbiology and Immunology

Pharmaceuticals

Osama M. Ahmed, (born in November 24, 1970) is a professor of physiology at Faculty of Science, Beni-Suef University. He has granted Ph. D. in Physiology from Faculty of Science, Cairo University, Egypt at year 2000. He is working in different research fields including diabetes mellitus, obesity, carcinogenesis, drug-induced toxicity, rheumatoid arthritis, hyperoxaluria, hyperhomocysteinemia, hypothyroidism, hyperthyroidism and assessment of medicinal plant their constituents as well as novel synthetic organic compounds as protective, preventive and therapeutic remedies. He holds more than 82 publications in the fields of his expertise in international journals. He has written two book chapters titled "Recent Advances in Chemistry and Biology of Natural Products" and "a New Look Hypothyroidism". He is a Deputy-Editor of Beni-Suef University Journal of Basic and Applied Sciences (BJBAS). He is a Co-PI of Experimental Obesity and Type 2 Diabetes Research Project granted by Science and Technology Development Fund (STDF), Egypt. He is a principal investigator and co-investigator in many research projects. He has taught physiology course for students in Faculty of Science, Faculty of Education (Biology Branch), and Faculty of Arts (Psychology Branch) in Beni-Suef University (Egypt) and for students in Faculty of Oral and Dental Medicine (Nahda University, Beni-Suef, Egypt).

Studies on Experimentally-induced type 1 and 2 diabetes and its treatment with medicinal plants and plant constituents

- Hepatotoxicity and anti-tumor activities.

- Experimentally-induced hypo- and hyper-thyroidism.

- Chemically-induced carcinogenicity and the treatment of cancer with natural products and newly synthesized organic compounds.

Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods, etc. He has participated at more than one hundred reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Spain, Portugal, Mexico, Japan, Malaysia, Thailand, Taiwan, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books and book chapters in Chemistry. Syne, he has been awarded more than seven hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA.

Oncology

Anti–Cancer Nano Drugs

Medicinal Chemistry

Biomolecular Spectroscopy

Nanochemistry

Dr. Chong-Kil Lee completed Microbiology and Immunology, University of Health Sciences/The Chicago Medical School, IL, USA. Director in Research Institute for development of pharmaceutical resources, Chungbuk National University. Dr. Chong-Kil Lee clinical interest is in Efficient generation of tolerogenic dendritic cells. His research interests are Modulation of MHC-restricted antigen presentation, Immunomodulatory activities of natural products

Efficient generation of tolerogenic dendritic cells

Modulation of MHC-restricted antigen presentation

Immunomodulatory activities of natural products

Dr. Haineng Xu completed Ph.D in Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Presently Postdoc fellow in University of Pennsylvania Perelman School of Medicine, Department of Radiation Oncology. Research experiences in Targeting cancers with specific and combined gene therapy and viro-therapy, Studying cancer micro-environment and cancer stem cells.

Gene therapy, Adenovirus, oncolytic adenovirus, cancer therapy, acetylcholinesterase liver cancer, lung cancer, gastric cancer, brain cancer, Cancer micro-environment

I am the Chief of Genitourinary Pathology at Northwell Health System, NY and Assistant Professor at Hofstra Northwell School of Medicine, NY; I am also the Director of Selective (Surgical) Pathology Fellowship, Northwell Health, NY and Associate Medical Director in the Department of Pathology at North Shore University Hospital, NY. I received my Medical Degree with Honors from Danylo Halytsky Lviv Medical University, Ukraine in 2001, followed by Anatomic and Clinical Pathology Residency at North Shore-LIJ Health System-Hofstra School of Medicine, NY, and fellowships in Selective (Surgical) Pathology at Washington University School of Medicine in Saint Louis MO and Genitourinary pathology Fellowship at Cleveland Clinic in Cleveland, OH. I am a board-certified pathologist in anatomic and clinical pathology with expertise in the surgical pathology of tumors of the genitourinary system.

Research interests include early detection and diagnosis of prostate cancer with involvement in studies focused on identifying better ways to detect clinically significant prostate cancer and the use of ancillary methods of detecting limited prostate cancer. Additional research interests include the study of clinical behavior of renal carcinomas and use of novel markers in the diagnosis of prostate and urothelial carcinoma.

Dr. Alexander Birbrair is a professor at Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, Brazil. He is also member in American Heart Association, Western NC Chapter of the Society for Neuroscience and International Society for Stem Cell Research. He has more than thirteen peer reviewed papers.He was Winner of 3-minute thesis (3MT) oral competition (2014 Fourteenth Annual Wake Forest University Graduate Student & Postdoc Research Day) 2014. Awarded with the Glenn/AFAR Scholarship for Research in the Biology of Aging.

Oncology and Pathology.

Following his residency, he was appointed as an Assistant Lecturer after obtaining a Master Degree in Pediatrics in 2007. Dr. Morsy is currently a Lecturer after he was awarded the M.D. degree in Pediatric Oncology in 2014. Dr. Morsy has published various high-quality original research, review articles & commentaries in several peer-reviewed journals with an international reputation. He has been a member of the Editorial Board & served as a Reviewer for many peer-reviewed scientific medical journals. He also holds professional memberships in renowned societies and attended some conferences as a speaker.

Dr. Ahmed Morsy's research interests include issues related to childhood cancer either the clinical or translational aspects of hematologic malignancies or solid tumors in children with cancer.